UNSPSC 51284127: Cefetamet pivaloyloxymethyl ester

This classification denotes a cephalosporin antibiotic with the molecular formula C20H25N5O7S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F6XA85N260, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6r-(6.alpha.,7.beta.(z)))-, but more generally known as cefetamet pivaloyloxymethyl ester, which bears US NIH Compound Identifier 5485222.

European Medicines Agency schedules cefetamet pivaloyloxymethyl ester or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07391MIG. Most nations, for tariff purposes, schedule cefetamet pivaloyloxymethyl ester under HS 29419000. SMILES: CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3CSC(N3)N)SC1)C(=O)OCOC(=O)C(C)(C)C.

UNSPSC 51284127 Cefetamet pivaloyloxymethyl ester is a Commodity code that nominally refers to a specific antibiotic compound, but recent state and local procurement activity under this code shows limited alignment with the pharmaceutical ingredient itself. The recent opportunities tagged to this code involve purchase of finished pharmaceutical products—antibiotic tablets (Doxycycline Hyclate, Ciprofloxacin Hydrochloride), opioid-reversal medication (Naloxone), and drug deactivation systems—rather than the active ingredient named in the code. State and local health agencies and counties are the primary issuing bodies using this code, acquiring pharmaceuticals and related products through both piggyback cooperative purchasing vehicles and direct competitive bids to support public health and emergency response missions.

Recent activity appears concentrated in the Midwest and Southeast. The Illinois Department of Public Health awarded a $2.99 million pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets over a 12-month initial term with two renewal options. Seminole County, Florida issued an IFB in June 2026 for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries, a two-year initial term, and a one-year renewal option; the solicitation required electronic bid submission through the county's e-Procurement Portal with all shipping costs included in vendor pricing. Mismatch between the code's nominal scope and the actual products being purchased suggests this code may be misapplied in state and local systems, or procurement offices are using it as a catch-all for pharmaceutical supply categories beyond the specific active ingredient it nominally identifies.